Activation of NF-kappaB, AP-1 and STAT transcription factors is a frequent and early event in human hepatocellular carcinomas

Journal of Hepatology

Volumn 37, Issue 1, 2002, Pages 63-71

  Liu, Ping ^a   Kimmoun, Elisabeth ^a   Legrand, Agnès ^a   Sauvanet, Alain ^b   Degott, Claude ^c   Lardeux, Bernard ^a   Bernuau, Dominique ^a  

^a INSERM   (France)

^b BEAUJON HOSPITAL   (France)

^c Hôpital Beaujon   (China)

Author keywords

AP 1; Fos; Jun; Nuclear factor kappa B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; CYCLINE; DNA BINDING PROTEIN; MESSENGER RNA; PROTEIN C FOS; PROTEIN C JUN; STAT1 PROTEIN; STAT1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ARTICLE; CANCER STAGING; CONTROLLED STUDY; DNA BINDING; ELECTROPHORETIC MOBILITY; GENE ACTIVATION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER METASTASIS; PHENOTYPE; PRIORITY JOURNAL; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; METABOLISM; PATHOPHYSIOLOGY;

CARCINOMA, HEPATOCELLULAR; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; NF-KAPPA B; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR AP-1;

EID: 0035988849     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00064-8     Document Type: Article

References (44)

1. Risk factors for hepatocellular carcinoma among patients with chronic liver disease
2. Hepatocyte death in hepatocarcinogenesis
3. Dysregulation of apoptosis in hepatocellular carcinoma
4. Structure, regulation and function of NF-kappa B
5. Rel/NF-kappaB/I kappaB family: Intimate tales of association and dissociation
6. NF-kappaB as a primary regulator of the stress response
7. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
8. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death
9. Suppression of TNF-alpha-induced apoptosis by NF-kappaB
10. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
11. Inhibition of NF-κB activity induces apoptosis in murine hepatocytes
12. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death
13. The role of Jun, Fos, and the AP-1 complex in cell-proliferation and transformation
14. AP-1 function and regulation
15. AP-1 in cell proliferation and survival
16. STATs and gene regulation
17. Activation of STAT transcription factors in oncogenic tyrosine kinase signaling
18. STAT signalling in cell proliferation and in development
19. Virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases
20. Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer
21. Putative role of hepatitis B virus X protein in hepatocarcinogenesis: Effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways
22. Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma
23. Increased MAPK expression and activity in primary human hepatocellular carcinoma
24. Activation of ras oncogene in livers with cirrhosis
25. The hepatitis B virus MHBst167 protein is a pleiotropic transactivator mediating its effect via ubiquitous cellular transcription factors
26. Modulation of intracellular signal transduction pathways by the hepatitis B virus transactivator pX
27. Constitutive activation of nuclear factor κB in hepatocellular carcinoma
28. Activation of nuclear factor kB in hepatitis C virus infection: Implications for pathogenesis and hepatocarcinogenesis
29. Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor κB independently of IκB degradation
30. NFY or a related CCAAT binding factor can be replaced by other transcriptional activators for co-operation with HNF1 in driving the rat albumin promoter in vivo
31. Hepatocyte growth factor activates the AP-1 complex: A comparison between normal and transformed rat hepatocytes
32. Direct solution hybridization of guanidine thiocyanate-solubilized cells for quantitation of mRNAs in hepatocytes
33. Regulation of proliferating cell nuclear antigen during the cell cycle
34. Cellular and molecular mechanisms of hepatocarcinogenesis
35. Mechanisms of liver tumor promotion
36. X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis
37. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity
38. Inactivation of SSI-1, a JAK/STAT inhibitor, in human hepatocellular carcinomas, as revealed by two-dimensional electrophoresis
39. Loss of JunB activity enhances stromelysin 1 expression in a model of the epithelial-to-mesenchymal transition of mouse skin tumors
40. Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras
41. JunD protects cells from p53-dependent senescence and apoptosis
42. Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription
43. Transcriptional regulation of cell invasion: AP-1 regulation of a multigenic invasion programme
44. Activators and target genes of Rel/NF-κB transcription factors